Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
881.8 USD | -1.00% | -1.88% | +0.19% |
02:45pm | Oppenheimer Adjusts Price Target on Regeneron Pharmaceuticals to $1,175 From $1,125 | MT |
Apr. 25 | Regeneron Pharmaceuticals Receives a Shareholder Proposal from John Chevedden | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.19% | 95.71B | |
-3.23% | 103B | |
+0.38% | 22.02B | |
-17.05% | 20.9B | |
-9.49% | 17.85B | |
-42.83% | 16.21B | |
-15.72% | 15.52B | |
+4.33% | 13.86B | |
+31.16% | 12.04B | |
-24.91% | 8.08B |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.
- Transcript : Regeneron Pharmaceuticals, Inc. Presents at Morgan Stanley 20th Annual Global Healthcare Conference, Sep-12-2022 11